…Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory progression to metabolic dysfuncti…
MASLD
This disease is selected. Its supporting articles are shown below.
Articles mentioning MASLD
77 articles · page 5 of 7…Objective Chronic liver disease (CLD) deaths in the UK have risen fivefold since 1970. People w…
…Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is driven by dysregulated lipid metabolism, oxidative stress, a…
….Methods This retrospective cohort study included patients with T2DM from Hong Kong (HK-T2DM cohort) and patients with T2DM and meta…
… tools including FIB-4, perform poorly in lean individuals with MASLD, yet the extent of this failure across racial/ethnic groups and…
…ipidaemia were independently associated with both steatosis and liver fibrosis (IDDF2026-ABS-0345 Table 1). Metabolic-related liver fibrosis a…
…=1.26, p<0.001), younger age (per year: exp(β)=0.992, p<0.001), cirrhosis (exp(β)=1.13, p=0.014), MASLD (exp(β)=1.31, p<0.001), and hazar…
…hest rates of hypertension (60.2%), type 2 diabetes (31.8%) and chronic kidney disease (23.3%). This phenotype portended the poorest 6-year survival (…
…is a progressive condition that may lead to liver cirrhosis and hepatocellular carcinoma. It is strongly associated with cardiometabolic diseases such a…
…Background and Aims Liver disease is a growing public health concern worldwide with increasing mo…
…Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than a third of the world’s adult population, maki…
…Introduction Chronic hepatitis B (CHB) remains a major cause of inflammatory liver disease worldwide. …